My Cart

PE-Labeled Human Her2 / ErbB2 Protein, His Tag (Site-specific conjugation)

Customer Reviews
Cat. No. / Size
Price
Qty
HE2-HP2E3-25tests
$345.00
HE2-HP2E3-200tests
$2140.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Synonyms

    ERBB2, CD340, HER-2, neu, HER2, MLN19, NEU, NGL, TKR1

  • Source

    PE-Labeled Human Her2, His Tag (HE2-HP2E3) is produced via conjugation of PE to Human Her2, His Tag under optimal conditions. Human Her2, His Tag is expressed from human 293 cells (HEK293). It contains AA Thr 23 - Thr 652 (Accession # P04626-1).

    Predicted N-terminus: Thr 23

    Request for sequence

  • Molecular Characterization

    Her2 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 73.0 kDa.

  • Conjugate

    PE

    Excitation Wavelength: 488 nm / 561 nm

    Emission Wavelength: 575 nm

  • Application

    Evaluation of anti-HER2 CAR expression by flow cytometry. Please note that this product is NOT compatible to streptavidin detection system.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, 0.5% BSA, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-FACS

     Her2 FACS

    5e5 of anti-Her2 CAR-293 cells were stained with 100 μL of 1:25 dilution (4 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human Her2, His Tag (Cat. No. HE2-HP2E3) and negative control protein respectively. PE signal was used to evaluate the binding activity (QC tested).

    Protocol

Customer Reviews
Writing Reviews

  • I***l2024-09-27
    Likes
    We used the PE-labeled recombinant ErbB2 protein to detect our HER2-specific CAR constructs. The protein performed exceptionally well, providing a strong and consistent fluorescence signal when analyzing stained samples via flow cytometry. The staining was highly specific, since we detected no background-signal on parental cell-lines lacking the CAR. This is in contrast to staining of CAR expressing cells using ErbB2-Fc in combination with secondary antibodies which often results in higher non-specific signals and is more time consuming. Hence, ErbB2-PE is a valuable tool to detect ErbB2-specific CAR expression via Flow cytometry.

Background

Human Epidermal growth factor Receptor 2 (HER2) is also called ERBB2, HER-2,HER-2 /neu, NEU, NGL,TKR1 and c-erb B2,and is a protein giving higher aggressiveness in breast cancers. It is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family. HER2 is a cell membrane surface-bound receptor tyrosine kinase and is normally involved in the signal transduction pathways leading to cell growth and differentiation. HER2 is thought to be an orphan receptor, with none of the EGF family of ligands able to activate it. Approximately 30% of breast cancers have an amplification of the HER2 gene or overexpression of its protein product. Overexpression of this receptor in breast cancer is associated with increased disease recurrence and worse prognosis. HER2 appears to play roles in development, cancer, communication at the neuromuscular junction and regulation of cell growth and differentiation .

Recent Advances

 
Drug Development Progress
  • English Name:

    Receptor protein-tyrosine kinase erbB-2

  • Category:

  • Approved Drugs:

    47 Details

  • Drugs in Clinical Trials:

    238 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background